The presence of rhabdoid cells has been reported in various types of malignant neoplasms. Thirty-six cases of extraskeletal myxoid chondrosarcoma (EMC) were reviewed, and three of them revealed rhabdoid features. These cases contained cells having prominent eosinophilic globular cytoplasm, but were otherwise typical of EMC. Immunohistochemically, cytokeratin (CAM 5.2) was positive in three of 20 cases (15%), including two of the three with rhabdoid features. The rhabdoid cells were also immunostained with vimentin. The 5-year survival rate in the 26 cases with follow-up information was 73%, and the 10-year survival rate was 63%. The cases with rhabdoid features had a significantly poorer prognosis (p=0.0271). This study suggests that presence of rhabdoid features is a predictor of aggressive behavior in EMC, as it was shown to be in other mesenchymal neoplasms.
1. Enzinger FM, Shiraki M.Extraskeletal myxoid chondrosarcoma: An analysis of 34 cases. Hum Pathol3:421-435, 1972
2.
2. Saleh G, Evans HL, Ro JY, Ayala AG. Extraskeletal myxoid chondrosarcoma. A clinicopathologic study of ten patients with long-term follow-up. Cancer70:2827-2830, 1992
3.
3. Antonescu CR, Argani P, Erlandson RA, Healey JH, Ladanyi M, Huvos AG. Skeletal and extraskeletal myxoid chondrosarcoma: A comparative clinicopathologic, ultrastructural, and molecular study. Cancer83:1504-1521, 1998
4.
4. Meis-Kindblom JM, Bergh P, Gunterberg B, Kindblom LG. Extraskeletal myxoid chondrosarcoma. A reappraisal of its morphologic spectrum and prognostic factors based on 117 cases. Am J Surg Pathol23:636-650, 1999
5.
5. Harris M, Eyden BP, Joglekar VM. Rhabdoid tumor of the bladder. A histological, ultrastructural, and immunohistochemical study. Histopathol11:1083-1092, 1987
6.
6. Tsuneyoshi M, Daimar Y, Hashimoto H, Enjoji M. The existence of rhabdoid cells in specified soft tissue sarcomas. Histopathological, ultrastructural, and immunohistochemical evidence. Virch Arch A411:509-514, 1987
7.
7. Hunt SJ, Anderson WD. Malignant rhabdoid tumor of the liver. A distinct clinicopathologic entity. Am J Clin Pathol94:645-648, 1990
8.
8. Oda Y, Hashimoto H, Tsuneyoshi M, Takeshita S.Survival in synovial sarcoma: A multivariate study of prognostic factors with special emphasis on the comparison between early death and long-term survival. Am J Surg Pathol17:35-44, 1993
9.
9. Ueyama T, Nagai E, Yao T, Tsuneyoshi M.Vimentinpositive gastric carcinomas with rhabdoid features. A clinicopathologic and immunohistochemical study. Am J Surg Pathol17:813-819, 1993
10.
10. Parham DM, Weeks DA, Beckwith JB. The clinicopathologic spectrum of putative extrarenal rhabdoid tumors: An analysis of 42 cases studied with immunohistochemistry or electron microscopy. Am J Surg Pathol18:1010-1029, 1994
11.
11. Matsukuma S, Aida S, Hata Y, Sugiura Y, Tamai S.Localized malignant peritoneal mesothelioma containing rhabdoid cells. Pathol Int46:389-391, 1996
12.
12. Cavazza A, Colby TV, Tsokos M, Rush W, Travis WD. Lung tumors with a rhabdoid phenotype. Am J Clin Pathol105:182-188, 1996
13.
13. McCluggage WG, Date A, Bharucha H, Toner PG. Endometrial stromal sarcoma with sex cord-like areas and focal rhabdoid differentiation. Histopathol29:369-374, 1996
14.
14. Utsunomiya T, Yao T, Masuda K, Tsuneyoshi M. Vimentin-positive adenocarcinomas of the stomach: Co-expression of vimentin and cytokeratin. Histopathol29:507-516, 1996
15.
15. Guillou L, Wadden C, Coindre JM, Krausz T, Fletcher CD. ‘Proximal-type’ epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series. Am J Surg Pathol21:130-146, 1997
16.
16. Nishihara K, Katsumoto F, Kurokawa Y, Toyoshima S, Takeda S, Abe R.Anaplastic carcinoma showing rhabdoid features combined with mucinous cystadenocarcinoma of the pancreas. Arch Pathol Lab Med121:1104-1107, 1997
18. Perry A, Scheithauer BW, Stafford SL, Abell-Aleff PC, Meyer FB. “Rhabdoid” meningioma: An aggressive variant. Am J Surg Pathol22:1482-1490, 1998
19.
19. Machen SK, Easley KA, Goldblum JR. Synovial sarcoma of the extremities: A clinicopathologic study of 34 cases, including semi-quantitative analysis of spindled, epithelial, and poorly differentiated areas. Am J Surg Pathol2:268-275, 1999
20.
20. White FV, Dehner LP, Belchis DA, Conard K, Davis MM, Stocker JT, Zuppan CW, Biegel JA, Perlman EJ. Congenital disseminated malignant rhabdoid tumor: A distinct clinicopathologic entity demonstrating abnormalities of chromosome 22ql 1. Am J Surg Pathol2:249-256, 1999
21.
21. Fanburg-Smith JC, Hengge M, Hengge UR, Smith JS Jr, Miettinen M.Extrarenal rhabdoid tumors of soft tissue: A clinicopathologic and immunohistochemical study of 18 cases. Ann Diagn Pathol2:351-362, 1998
22.
22. Tsuneyoshi M, Enjoji M, Iwasaki H, et al. Extraskeletal myxold chondrosarcoma: A clinicopathologic and electron microscopic study. Acta Pathol Jpn31:439-447, 1981
23.
23. Fletcher CD, Powell G, McKee PH. Extraskeletal myxoid chondrosarcoma: A histochemical and immunohistochemical study. Histopathol10:489-499, 1986
24.
24. Wick MR, Ritter JH, Dehner LP. Malignant rhabdoid tumors: A clinicopathologic review and conceptual discussion. Semin Diagn Pathol12:233-248, 1995
25.
25. O'Hara BJ, Paetau A, Miettinen M.Keratin subsets and monoclonal antibody HBME-1 in chordoma: Immunohistochemical differential diagnosis between tumors simulating chordoma. Hum Pathol29:119-126, 1998
26.
26. Brody RI, Ueda T, Hamelin A, Jhanwar SC, Bridge JA, Healey JH, Huvos AG, Gerald WL, Ladanyi M.Molecular analysis of the fusion of EWS to an orphan nuclear receptor gene in extraskeletal myxoid chondrosarcoma. Am J Pathol150:1049-1058, 1997
27.
27. Clark J, Benjamin H, Gill S.Fusion of the EWS gene to CHN, a member of the steroid/thyroid receptor gene superfamily, in a human myxoid chondrosarcoma. Oncogene12:229-235, 1996
28.
28. Labelle Y, Zucman J, Stenman G, Kindblom L-G, Knight J, Turc-Carel C, Dockhorn-Dworniczak B, Mandahl N, Desmaze C, Peter M, Aurias A, Delattre O, Thomas G.Oncogenic conversion of a novel orphan nuclear receptor by chromosome translocation. Hum Mol Genet4:2219-2226, 1995
29.
29. Orndal C, Carlen B, Akerman M, Willen H, Mandahl N, Heim S, Rydholm A, Mitelman F.Chromosomal abnormality t(9;22)(q22;ql2) in an extraskeletal myxoid chondrosarcoma characterized by fine needle aspiration cytology, electron microscopy, immunohistochemistry, and DNA flow cytometry. Cytopathol2:261-270, 1991
30.
30. Sciot R, Dal Cin P, Fletcher C, Samson I, Smith M, De Vos R, Van Damme B, Van den Berghe H.t(9;22)(q22-31;qll-12) is a consistent marker of extraskeletal myxoid chondrosarcoma: Evaluation of three cases. Mod Pathol8:765-768, 1995
